Antibacterial Drugs Market

XPLREP4476
November, 2019
170 Pages
Drug Discovery

Get Free Sample Report

Increasing Prevalence of Infectious Diseases Drives Antibacterial Drugs Market on a Remunerative Path

The global antibacterial drugs market is forecasted to expand at a steady rate during the forecast period (2019 to 2027), according to a new market study by XploreMR. Antibacterial drugs, also referred to as antibiotics are medicines that eliminate the presence and restrain the growth of microorganisms such as bacteria, which cause numerous skin diseases. The growth of the market is majorly attributed to the rising prevalence of antibacterial and infectious diseases and rising awareness among consumers regarding the diseases.

Furthermore, factors such as increasing geriatric population, strong demand for effective yet affordable antibacterial drugs, a burgeoning number of multidrug-resistant bacterial strains will equally complement the growth of the market in the years to come. Besides, the demand for antibacterial drugs will also be upheld on the back of growing demand for developing innovative molecules and novel treatments for treating infections. On the back of these factors, the global antibacterial drugs market, which was valued at US$ 46.37 in 2018, will witness steady growth during the forecast period.

Rising Geriatric Population Drives Demand

Increasing Prevalence of Infectious Diseases Drives Antibacterial Drugs Market on a Remunerative Path

Rising Geriatric Population Drives Demand

A study named "Infection in an aging population", in 2016 estimated that the geriatric population is proliferating. At present, more than 566 Mn people across the world are above 65 years of age, and the number is expected to burgeon to 1.5 Bn by 2050. Moreover, the study also revealed that infections are the third cause of death in people above 65 years with the risk of nosocomial infections growing directly in proportion with age. Along similar lines, a study by the World Health Organization (WHO), estimated that antibiotic-resistant bacteria are responsible for up to 60% of hospital-acquired infections (HAI) in the United States.

Such bacterial will severely affect patients for long periods and patients with weaker immune systems are at high risk of succumbing to the infection.In 2016, nearly 490,000 people were affected by multi-drug resistant tuberculosis globally, and drug resistance is starting to complicate the fight against HIV and malaria, as well. The aforementioned factors are creating a huge opportunity for antibacterial drugs.

Supportive Government Policies Increase Availability of Drugs

Introduction of favorable government policies is also proving fruitful to market growth. For instance, the Generic Drug User Fee Amendments (GDUFA), passed by U.S. Congress in 2012, is expediting the U.S. Food and Drug Administration's approval of new generic drugs, thus increasing the availability of drugs. As a result, the wide availability of over the counter (OTC) antibacterial drugs are expected to further fuel the growth of the market.

Segmental Highlights: B-lactam and North America Drive Majority of Revenue

On the basis of drug class, the global antibacterial drugs market is segmented into B-lactam, quinolones, macrolides, tetracycline, aminoglycoside, sulfonamide, phenicols, and others. Among these, B-lactam is forecasted to account for majority of market share as it’s one of the most commonly prescribed drug classes, coupled with high usage of penicillin and also

On the regional front, North America led the region in 2018 and will remain at the forefront of market growth through the assessment period, backed by a high incidence of infectious diseases, increased spending on research and developmental activities, and presence of a well-established healthcare sector. On the other hand, Asia Pacific is projected to grow at the highest CAGR owing to the flourishing presence of the pharmaceutical sector in India, China, Indonesia, Vietnam, South Korea, and the Philippines. Furthermore, factors such as increasing patient population, high prevalence of infectious diseases, and high government expenditure on healthcare

Competitive Landscape of Antibacterial Drugs Market

The Key players of the global antibacterial drugs market include Bayer AG, Pfizer Inc., Sanofi, GlaxoSmithKline plc., Merck & Co., Inc., AstraZeneca, Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Novartis AG, and Allergan, among others.

Antibacterial Drugs Market - Scope of the Study

XploreMR, in its exclusive research report on the antibacterial drugs market, highlights actionable insights and winning imperatives for stakeholders. This comprehensive study unfolds rare and distinguished intelligence regarding impactful dynamics, which directly or indirectly influence the growth of the antibacterial drugs during the forecast period (2020-2025). With the help of crucial insights discussed in this study, stakeholders will gain a thorough idea regarding the growth trajectory of the antibacterial drugs market.

This comprehensive study offers incisive data regarding the drivers, threats, restraints, and opportunities present in the antibacterial drugs market. The study also recalibrates the impact of each of these dynamics to estimate the size of the antibacterial drugs market for the given period. Authors of the report have taken ample care to measure and include the relevance and impact of microeconomic as well as macroeconomic factors that holds potential to influence growth of the antibacterial drugs market during the forecast period.

The global study on the antibacterial drugs market includes Porter’s Five Forces analysis, in order to present the buyer’s and supplier’s power in the landscape. In addition, the analysis also discusses the threat of substitutes and new entrants, which provides a brief idea regarding the future growth course of the antibacterial drugs market.

Antibacterial Drugs Market - Scope of the Study

The global study offers crucial information about global, regional, and local players operating in the antibacterial drugs market, along with their estimated market share. Market share has been estimated in terms of value (US$ Mn). Besides providing key information regarding the concentration of leading, prominent, and local players in the antibacterial drugs market, the study also aims at equipping stakeholders with the best of information regarding their winning strategies, recent developments, and financials.

Antibacterial Drugs Market - Assessment of Key Segments

With an aim to offer granular level insights into the antibacterial drugs market, authors of the report have segmented the landscape on the basis of drug class, route of administration, distribution channel, and region. This global research report also analyses the incremental opportunity available in the antibacterial drugs market during the forecast period. Key segments of the antibacterial drugs market include:

Drug Class	Route of Administration	Distribution Channel	Region
ß-lactams	Enteral	Hospital Pharmacies	North America
Quinolones	Parenteral	Drug Stores and Retail Pharmacies	Europe
Macrolides	Others (Inhalation, Topical, etc.,)	Online Sales	Asia Pacific
Tetracycline			Latin America
Aminoglycosides			Asia Pacific
Sulfonamide
Phenicols
Others

This detailed guide, based on the latest market movement, ensures that only precise information reaches stakeholders, so as to help them gain an upper hand over their competitors in the antibacterial drugs market. This exclusive guide offers crucial information about the current trends, pipeline drugs, unmet drugs, future scope, and government regulations for the antibacterial drugs market.

Key market players profiled in this comprehensive study on the antibacterial drugs market include Allergan PLC, Bristol-Myers Squibb Company, Novartis AG, Johnson & Johnson, AstraZeneca, Merck & Co., Inc., Bayer AG, GlaxoSmithKline PLC, Sanofi, and Pfizer, Inc. Authors of the study have analysed the antibacterial drugs market in detail, and estimated market values based on the robust research methodology adopted by them.

Antibacterial Drugs Market - Research Methodology

Research undertaken by the seasoned analysts at XploreMR consists of a systematic approach, including both, primary and secondary research methodologies. For conducting primary research, interviews and discussions were carried out with industry experts, key opinion leaders, vendors, and distributors. Besides these, respondents also include CEOs, presidents, directors, chairmen, vice presidents, marketing managers, suppliers, distributors, and chief medical officers, among others. This helps in assessing the demand-supply gap prevailing in the antibacterial drugs market.

In order to conduct secondary research, marketing collaterals, company websites, industry associations, and government statistics were studied. In addition to this, reports as well as content pieces published by credible sources, such as the American Medical Association, Therapeutic Advances in Gastroenterology, The White Rose University Consortium, Centres for Disease Control and Prevention, the Infection Disease Clinics of North America, and others, were studied.

Insights obtained through primary and secondary research are then authenticated with the data triangulation method.

Antibacterial Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Buy Now

Custom Market Research Services

xploreMR offers custom market reserch services that help clients to get information on their business scenario required where syndicated solutions are not enough

Get Free Custom Research Quote

Why Choose XploreMR

Analyst Support

Our analysts go above and beyond to answer your specific queries. We are with you throughout the entire journey – from initial discussion to post-purchase.
Country-wise Analysis & Forecasting

As we track markets at country-level, we are able to offer hard-to-find market intelligence in both developed and emerging countries.
High Quality At Competitive Pricing

We believe high quality market research shouldn’t be out of reach for businesses. Our competitively-priced market research reports ensure businesses of all sizes have access to quality information

Popular Reports

Global Market Study on Cloud-based Drug Discovery Platforms: Pharmaceutical Vendors Projected to be the Most Attractive End User Segment Through 2025

About this Report Cloud has proliferated key aspects of business across multiple industries and the healthcare industry is no exception. The facilitation of drug discovery through the cloud is one of ...

Parenteral Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029

Parenteral Drugs Market – Report Scope XploreMR recently published a market study on the global market for parenteral drugs. The study provides detailed assessment on the key market dynamics, i ...

Antibacterial Drugs Market

Get Free Sample Report

Antibacterial Drugs Market